Pharma Journalist -

Bristol Myers Squibb and WuXi STA – a subsidiary of WuXi AppTec – announced that WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland.…
Read More...

Ocugen, Inc., and Bharat Biotech announced they have entered into a definitive agreement to co-develop, supply, and commercialize Bharat Biotech’s COVAXIN, an advanced stage…
Read More...

Engrail Therapeutics announced that it has acquired NeuroCycle Therapeutics, a company focused on sub-type selective GABA-A modulation. The acquisition strengthens Engrail’s presence in…
Read More...

Ampio Pharmaceuticals, Inc. a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced early positive data…
Read More...

Aeterna Zentaris Inc. through its wholly-owned subsidiary Aeterna Zentaris GmbH a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests…
Read More...

SMi Reports: Three AI in drug discovery start-ups to join the conference GlamourousAI, Cloud Pharmaceuticals and Envisagenics , who will be speaking at the 2nd Annual AI in Drug…
Read More...

Ribon Therapeutics, a clinical stage oncology company developing therapeutics targeting stress support pathways, announced it has entered into an exclusive license agreement with Ono…
Read More...

Gilead Sciences, Inc. and Gritstone Oncology, Inc. a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the…
Read More...

Evozyne, LLC, a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences, announced the signing of a strategic collaboration with a…
Read More...

ZebiAI, Inc., a biotech company focused on improving human health by powering machine learning (ML) to source novel targets and discover new therapeutics, announced a strategic…
Read More...